images

 

Modified citrus pectin-monograph.

Abstract

Modified citrus pectin (MCP), also known as fractionated pectin, is a complex polysaccharide obtained from the peel and pulp of citrus fruits. Modified citrus pectin is rich in galactoside residues, giving it an affinity for certain types of cancer cells. Metastasis is one of the most life-threatening aspects of cancer and the lack of effective anti-metastatic therapies has prompted research on MCP’s effectiveness in blocking metastasis of certain types of cancers, including melanomas, prostate, and breast cancers.

The review discusses MCP’s ability to control metastatic melanoma, as well as prostate, breast and colon cancers. These outcomes have been confirmed in multiple published studies, which have also shown MCP’s ability to suppress angiogenesis (new blood vessel growth to tumors). Blocking angiogenesis is a key factor in preventing cancer metastasis.

MCP has also been shown to induce apoptosis in cancer cells. Apoptosis, known as programmed cell death, is suppressed in tumors, allowing them to grow uncontrollably.  Numerous studies show MCP supports apoptosis in cancer, including a 2010 study from Columbia University which found that MCP induced apoptosis in both androgen dependent and androgen independent prostate cancer cells. This is particularly significant because androgen independent prostate cancer is a highly aggressive, difficult-to-treat cancer.

Other important findings demonstrate MCP’s abilities to make chemotherapy more effective. Co-administering MCP with cisplatin, etoposide or doxorubicin makes cancer cells more sensitive to these frontline treatments. MCP is also useful during radiation therapy, helping to protect organs from the damaging inflammatory effects of radiation.

Reference: 

Modified citrus pectin-monograph. Altern Med Rev. 2000 Dec;5(6):573-5. PubMed PMID: 11134980.

 

About the author: Dr. Mordy Levy

 

Dr. Mordy Levy, ND, DC, HOM, is possibly the only Canadian doctor to have graduated from three first professional doctorates in separate and distinct health care professions: Chiropractic Medicine (DC)-1997, Allopathic Medicine (MD)-2006, Naturopathic Medicine (ND)-2011, graduated Summa Cum Laude, from the prestigious National University of Health Sciences (Chicago, IL) and was the valedictorian of his graduating class.

Dr Levy's first undergraduate degree (BSc) was in Biology and Psychology from York University, and his second undergraduate degree (BMSc) was in Human Biology and Biomedical sciences from National University of Health Sciences (Chicago, IL)

Dr. Levy is a registered member in good standing with three distinct health professions in Ontario, namely the College of Chiropractors of Ontario, the College of Naturopaths of Ontario, in addition to the College of Homeopaths of Ontario. Dr. Levy is a professional member of the Institute of Functional Medicine, the Canadian Society of Orthomolecular Medicine, American College of Nutrition, in addition to the Ontario Association of Naturopathic Doctors, the Ontario Chiropractic Association and the Ontario Homeopathic Association. Always an avid lifelong learner, Dr. Levy completed numerous postgraduate certifications in Functional Medicine, Clinical Nutrition, Medical Acupuncture, Homeopathic Medicine, in addition to Prolotherapy regenerative medicine. His clinical interests are in Neurological, Autoimmune and Gastrointestinal Dysfunctions.
On a personal noted: Dr. Levy enjoys spending time with his three boys, practicing TaeKwonDo and reviewing research articles.

Website: http://www.DrLevy.ca